Literature DB >> 9420616

Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans?

M Johansson1, K Schön, M Ward, N Lycke.   

Abstract

Chlamydia trachomatis is one of the major causes of infertility and preventable blindness in the world. The organism is of particular interest from an immunological point of view because it is one of the few obligate intracellular bacterial pathogens. There is some evidence that repeated infections in humans stimulate protective immunity. However, until recently, it was unclear which components of the adaptive immune system give rise to protection. Studies in gene knockout mice reported here and elsewhere now give a coherent and cogent picture of the importance of the Th1 response, in particular IFN-gamma, for the localization and eradication of C. trachomatis genital tract infection. The key questions still to be addressed are the identity of the IFN-gamma responsive cells and whether the mouse is truly representative of host protection against chlamydiae in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9420616     DOI: 10.1046/j.1365-3083.1997.d01-167.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  28 in total

1.  T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens.

Authors:  A J Curry; I Portig; J C Goodall; P J Kirkpatrick; J S Gaston
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.

Authors:  J M Vuola; V Puurula; M Anttila; P H Mäkelä; N Rautonen
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge.

Authors:  Nina Dieu Nhien Tran Nguyen; Anja W Olsen; Emma Lorenzen; Peter Andersen; Malene Hvid; Frank Follmann; Jes Dietrich
Journal:  NPJ Vaccines       Date:  2020-01-23       Impact factor: 7.344

4.  Early Colonization of the Upper Genital Tract by Chlamydia muridarum Is Associated with Enhanced Inflammation Later in Infection.

Authors:  Jennifer D Helble; Nicole V Reinhold-Larsson; Michael N Starnbach
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

Review 5.  Pathogenesis of Chlamydia induced pelvic inflammatory disease.

Authors:  C R Cohen; R C Brunham
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

6.  Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells.

Authors:  M Johansson; N Lycke
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

7.  Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract.

Authors:  Gail L Sturdevant; Harlan D Caldwell
Journal:  Pathog Dis       Date:  2014-04-10       Impact factor: 3.166

8.  Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.

Authors:  Rhea N Coler; Ajay Bhatia; Jean-Francois Maisonneuve; Peter Probst; Brenda Barth; Pamela Ovendale; Hang Fang; Mark Alderson; Yves Lobet; Joe Cohen; Pascal Mettens; Steven G Reed
Journal:  FEMS Immunol Med Microbiol       Date:  2009-03

9.  A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.

Authors:  Eno E Ekong; Daniel N Okenu; Jayanti Mania-Pramanik; Qing He; Joseph U Igietseme; Godwin A Ananaba; Deborah Lyn; Carolyn Black; Francis O Eko
Journal:  FEMS Immunol Med Microbiol       Date:  2008-11-18

10.  Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition.

Authors:  Malgosia K Matyszak; J S Hill Gaston
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.